Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

celgene_1_02

Celgene’s Otezla hits primary endpoint in psoriatic arthritis study

November 15, 2016 Manufacturing and Production, Research and Development Celgene, otezla, psoriatic arthritis

Celgene has unveiled new data on its selective inhibitor of phosphodiesterase 4 (PDE4) Otezla (apremilast) which shows that the treatment …
News
abbvie_0

AbbVie investigational hep C drug boasts 97.5% response rate

November 15, 2016 Manufacturing and Production, Medical Communications, Research and Development AbbVie, hepatitis C, pan-genotypic

AbbVie released details on their latest trials for their investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530). In an eight week …
News

Novartis reveals positive three-year efficacy data for psoriatic arthritis drug

November 15, 2016 Manufacturing and Production, Research and Development Cosentyx, Novartis, psoriatic arthritis

Novartis has claimed that its Cosentyx (secukinumab) treatment is now the first approved fully human interleukin-17A (IL-17A) inhibitor to demonstrate …
News
adriane_brown

Allergan appoints Adriane M. Brown to board of directors

November 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan

Allergan announced that Adriana M. Brown will join its board of directors on February 2017. Adriana Brown is currently the …
Appointment

Free Pharmacovigilance Webinar: Available to view now!

November 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

Pharmafocus, alongside PrimeVigilance, hosted a webinar on 10 November and is now available to view for free.Throughout the webinar, PrimeVigilance …
News
richard_cm_jones

Mereo BioPharma appoint Richard Jones as CFO

November 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mereo BioPharma

Mereo BioPharma, a UK-based biopharmaceutical company, has announced that Richard CM Jones has been appointed chief financial officer of the …
Appointment

Experimental Novartis leukaemia and mastocytosis drug gets FDA Priority Review

November 14, 2016 Research and Development, Sales and Marketing FDA, Novartis, acute myeloid leukaemia

The US FDA has granted Priority Review status to Novartis’ experimental drug PKC412 (midostaurin) as a treatment for advanced systemic …
News
top_ten_1

Top Ten articles in the Pharma Industry this week

November 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing November, news, pharmaceutical, top 10, top ten, top ten stories

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …
News
ex-roche_guy

Former Roche CEO joins Arix Bioscience as senior independent director

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …
Appointment
nhs_trees

Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court

A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …
News
shutterstock_157775444

Social media and mobile apps: Bringing people and clinical trials together

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …
Feature

Pfizer’s breast cancer drug gets EU approval

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance

Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …
News
novavax

Novavax cuts works force by a third in struggle to restructure

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses

Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …
News
apps_mobile

Chinese FDA releases “drug scanner” app

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Food and Drug Administration, app

The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …
News
janssen_stairs

Collaboration on new therapeutic vaccine for HIV shows promise

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Janssen, Johnson & Johnson

Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026